Luxfer Group (NYSE:LXFR), a global materials technology
company, today issued its unaudited financial results for the
three-month and six-month periods ended June 30, 2014.
UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER OF
2014
Results are summarized as follows:
Three-month periods
ended June 30,
Six-month periods
ended June 30,
2014 2013
2014 2013
Net revenue (excluding surcharge
below)
$ 121.3m $ 120.4m $
243.7m $ 239.6m
Rare earth chemical surcharge
$ 0.6m $ 2.6m $ 1.5m
$ 5.8m
Revenue
$
121.9m
$ 123.0m $ 245.2m
$ 245.4m Trading profit $
11.2m $ 15.3m $ 23.5m $
30.2m
Trading margin
9.2 % 12.4 % 9.6 %
12.3 %
Operating profit
$ 10.4m $ 15.1m $
22.7m $ 29.6m Net income
$ 5.7m $ 8.6m $ 12.9m
$ 16.9m
Earnings per share – Basic (1)(2)
$ 0.21 $ 0.32 $
0.48 $ 0.63
Adjusted net income (3)
$ 7.6m $ 10.0m
$ 15.6m $ 19.4m
Adjusted earnings per share – Basic
(2)
$ 0.28 $ 0.37
$ 0.58 $ 0.72
Adjusted earnings per share – fully
diluted (2)
$ 0.27 $ 0.36
$ 0.55
$ 0.69
Adjusted EBITDA (4)
$ 16.2m $ 19.8m
$ 33.1m $ 38.5m
Adjusted EBITDA margin
13.3 % 16.1 %
13.5
% 15.7 %
Net cash (outflow)/inflow from operating
activities
($4.7m
)
$ 6.9m
($3.4m ) $ 16.5m
Net
debt (total debt less cash)
$
55.4m
$
26.6m
$ 55.4m $ 26.6m
Total
equity – book value (net assets)
198.9m
164.5m
198.9m 164.5m
£0.50 ordinary shares outstanding
$
26.9m
$ 26.8m
$ 26.9m $ 26.8m
(1) Basic earnings per share is calculated by dividing the
profit attributable to ordinary shareholders by the weighted
average number of ordinary shares outstanding in the period.
(2) Following the approval of a two-for-one share split at the
Annual General Meeting on May 29, 2014 and change in ADR ratio on
June 9, 2014, each £0.50 ordinary share now represents 1 American
Depositary Share (ADS), resulting in the earnings per ordinary
share being equivalent to the earnings per ADS. The ADS are listed
on the NYSE under the ticker LXFR. Under IAS 33, the number of
shares used in the earnings per share calculations for the prior
periods shown has been adjusted to achieve comparability.
(3) Adjusted net income consists of net income adjusted for the
post tax impact of non-trading items (being accounting charges
relating to acquisitions and disposals of businesses, IAS 19
retirement benefits finance charges, restructuring and other income
and expense and other share-based compensation charges). A
reconciliation to net income is disclosed in Note 4 to the
financial results “Reconciliation of non-GAAP measures”.
(4) Adjusted EBITDA consists of profit for the period before tax
expense, finance income and costs, accounting charges relating to
acquisitions and disposals of businesses, IAS 19 retirement
benefits finance charges, restructuring and other income and
expense, other share based compensation charges and amortization
and depreciation. A reconciliation to net income is disclosed in
Note 4 to the financial results “Reconciliation of non-GAAP
measures”.
CONTACTS
Investor and news agency communications should initially be
directed to Dan Stracner, Director of Investor Relations,
U.S. telephone number: +1 951 341 2375; email:
dan.stracner@luxfer.net.
COMMENTARY FOR THE THREE-MONTH AND SIX-MONTH PERIODS ENDED JUNE
30, 2014
ABOUT LUXFER GROUP
Luxfer is a global materials technology company specializing in
the design and manufacture of high-performance materials,
components and gas-containment devices for environmental,
healthcare, protection and specialty end-markets. Luxfer customers
include both end-users of its products and manufacturers that
incorporate Luxfer products into finished goods. For more
information, visit www.luxfer.com.
Luxfer Group is listed on the New York Stock Exchange, and its
American Depositary Shares (ADSs) trade under the symbol
“LXFR”.
BUSINESS REVIEW
Second-quarter Results
Despite several areas of the business performing well, trading
continued to be affected by disruption to some key North American
markets and by general weakness in Europe.
Luxfer Group revenue for the second quarter of 2014 was $121.9m
and, excluding rare earth chemical surcharges of $0.6m, net revenue
was $121.3m, a decrease of $2.8m (or 2.3%) over Q2 2013 at constant
translation exchange rates. FX translation differences were a
positive $3.7m. The divisional results are discussed in further
detail later in this release; however, in summary, both divisions’
net revenues were down at constant FX translation rates, with the
Gas Cylinders Division down 1.3% and the Elektron Division down
3.3% compared to Q2 2013. Lower sales of higher-added-value
composite life-support cylinders (affected by regulatory delays)
and medical composite cylinders were offset by higher sales of
lower-value traditional aluminum cylinders. The Elektron Division’s
net revenue was mainly down as a result of lower sales of zirconium
materials, partly offset by a stronger quarter from our magnesium
operations.
Lower rare earth costs, when compared to Q2 2013, resulted in a
reduced rare earth surcharge: down to only $0.6m in Q2 2014 from
$2.6m in Q2 2013; surcharges are ceasing to feature in price
negotiations, so they are not expected to be separated out from
other pricing after this year. The gross profit margin was lower at
22.4%, compared to 24.8% for Q2 2013. The main reason was an
adverse sales mix, including a fall in added-value product lines,
particularly in the Gas Cylinders Division, where higher-margin
composite cylinder sales were lower due in part to delays in
regulatory approval of customers’ U.S. SCBA kits.
Trading profit was $11.2m for the second quarter of 2014 (Q2
2013: $15.3m). The Gas Cylinders Division Q2 2014 trading profit
margin of 2.6% was much lower than the 7.4% in Q2 2013, depressed
by both the adverse sales mix on added-value product lines and high
costs related to product developments for the alternative fuel (AF)
and medical markets. These costs are running at over $1m a quarter
for 2014. The Elektron Division’s 17.0% trading profit margin was
slightly lower than in Q2 2013 (18.0%), mainly due to lower sales
in higher-margin products.
Group operating profit was $10.4m in Q2 2014 (Q2 2013: $15.1m)
after deducting $0.5m for restructuring costs in the Gas Cylinders
Division (Q2 2013: $0.1m), $0.2m for restructuring costs in the
Elektron Division (Q2 2013: $nil) and $0.1m share-based
compensation charges (Q2 2013: $0.1m).
FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements.
Examples of such forward-looking statements include, but are not
limited to:
(i) statements regarding the Group’s results of operations and
financial condition,
(ii) statements of plans, objectives or goals of the Group or
its management, including those related to financing, products or
services,
(iii) statements of future economic performance and
(iv) statements of assumptions underlying such statements. Words
such as “believes”, “anticipates”, “expects”, “intends”,
“forecasts” and “plans” and similar expressions are intended to
identify forward-looking statements but are not the exclusive means
of identifying such statements.
By their very nature, forward-looking statements involve
inherent risks and uncertainties, both general and specific, and
risks exist that the predictions, forecasts, projections and other
forward-looking statements will not be achieved. The Group cautions
that a number of important factors could cause actual results to
differ materially from the plans, objectives, expectations,
estimates and intentions expressed in such forward-looking
statements. These factors include, but are not limited to:
(i) future revenues being lower than expected; (ii) increasing
competitive pressures in the industry; (iii) general economic
conditions or conditions affecting demand for the services offered
by us in the markets in which we operate, both domestically and
internationally, being less favorable than expected; (iv) the
amount of indebtedness we have incurred and may incur and the
obligations to service such indebtedness and to comply with the
covenants contained therein; (v) fluctuations in the price of raw
materials and utilities; (vi) currency fluctuations and hedging
risks; and (vii) worldwide economic and business conditions and
conditions in the industries in which we operate.
The Group cautions that the foregoing list of important factors
is not exhaustive. These factors are more fully discussed in the
sections “Forward-Looking Statements” and “Risk Factors” in our
annual report on Form 20-F for the year ended December 31, 2013,
filed with the U.S. Securities and Exchange Commission on March 31,
2014. When relying on forward-looking statements to make decisions
with respect to the Group, investors and others should carefully
consider the foregoing factors and other uncertainties and events.
Such forward-looking statements speak only as of the date on which
they are made, and the Group does not undertake any obligation to
update or revise any of them, whether as a result of new
information, future events or otherwise.
Divisional analysis of revenue and trading profit
SECOND QUARTER 2014 SECOND QUARTER 2013
Gas Gas Cylinders
Elektron Group Cylinders Elektron
Group $M $M $M
$M $M $M Revenue
65.9 56.0 121.9 64.8 58.2 123.0
Net revenue
(excluding RE surcharge) 65.9 55.4 121.3
64.8
55.6 120.4
Trading profit 1.7 9.5
11.2 4.8 10.5 15.3
Return on Sales %
(Trading profit/Revenue)
2.6%
17.0%
9.2%
7.4% 18.0% 12.4%
Gas Cylinders
The Gas Cylinders Division’s revenue of $65.9m in Q2 2014 was
$1.1m higher than in Q2 2013. Underlying revenue (calculated as net
revenue before FX translation differences) decreased by $0.9m or
1.3%, and FX translation differences were a positive $2.0m. Q2 2014
remained depressed, with sales of composite life-support cylinders
used in self-contained breathing apparatus (SCBA) still impacted in
the quarter by the delay in regulatory approval for our customers’
SCBA kits compliant with the new U.S. standard, as previously
reported. This also had some knock-on impact with customers
rescheduling the launch of new products to later in the year. Sales
from our range of aluminum cylinders were favorable to Q2 2013,
with stronger demand for traditional aluminum cylinder products
helping to offset the disruption in the SCBA market and reduced
demand for composite cylinders used in healthcare markets.
Composite cylinder sales into the AF market were also slightly
down, with lower activity in the bus and medium truck conversion
markets.
Trading profit for the second quarter of 2014 was $1.7m, a
decrease of $3.1m or 64.6% from the $4.8m trading profit for the
second quarter of 2013. Though underlying revenue was only down
1.3%, trading profit was more impacted by the adverse sales mix
compared to Q2 2013, with lower composite cylinder sales. We also
continued to incur higher than normal product development and
market development costs in connection with new products in AF and
medical markets, as well as costs related to integrating into the
division our recently acquired Utah composite facility. Utah was
not producing any product as acquired and is currently being
re-commissioned to manufacture new Luxfer-branded Type 4 cylinders
beginning in Q3 2014.
Elektron
The Elektron Division’s revenue was $56.0m for Q2 2014, a
decrease of $2.2m from Q2 2013. The drop in rare earth costs
allowed us to reduce Q2 2014 rare earth surcharges to customers by
$2.0m to only $0.6m compared to Q2 2013. Q2 2014 net revenue was
down $0.2m to $55.4m compared to Q2 2013. FX translation
differences were a positive $1.7m on prior-year revenue, so
underlying revenue was down $1.9m or 3.3%. Our magnesium operations
outperformed Q2 2013 despite lower sales of magnesium powders for
defense countermeasure flares as a result of the previously
reported customer facility outage and general demand weakness in
the sector. Sales of high-performance aerospace alloys,
photo-engraving plate and automotive recycling all continued to
grow and were favorable compared to Q2 2013. Zirconium chemical
sales were lower in the quarter, with lower demand in some
non-automotive applications. Automotive demand, however, was
stable, but, as we expected, there was no repeat of the higher
industrial chemical sales seen in Q1 2014. Though still at
relatively low levels to other product lines, there was a
significant increase in sales of sorption chemicals, mainly
relating to supplying prototype material for customer development
projects.
The Elektron Division’s trading profit of $9.5m in Q2 2014 was
$1.0m lower than in Q2 2013. Trading profit decreased because of an
adverse sales mix in the quarter along with the lower underlying
revenue.
Operating profit to net income for the period
Operating profit was $10.4m in Q2 2014 compared to $15.1m in Q2
2013. There was $0.8m in Q2 2014 relating to restructuring and
other income or expense ($0.2m in Q2 2013). The new charges related
to headcount reductions across the Gas Cylinders Division and also
in our U.S. magnesium powders business in the Elektron
Division.
The net interest charge for Q2 2014 was $0.2m higher at $1.6m
(Q2 2013: $1.4m).
Profit on operations before tax was $7.9m for Q2 2014 (Q2 2013:
$12.8m). Tax expense was $2.2m (Q2 2013: $4.2m), and the effective
tax rate was 27.8% compared to 32.8% in Q2 2013, in line with our
expectations following tax-saving measures implemented in 2013.
Net income in the period was $5.7m (Q2 2013: $8.6m). Adjusting
for non-trading items (IAS 19 retirement benefits finance charges,
accounting charges relating to acquisitions and disposals of
businesses, restructuring and other income and expense and other
share-based compensation charges), adjusted net income in Q2 2014
was $7.6m (Q2 2013: $10.0m).
Earnings per ADS for Q2 2014, unadjusted, was $0.21. Using
adjusted net income, earnings per ADS was $0.28. The fully diluted
adjusted earnings per ADS was $0.27, the result impacted by the
depressed Gas Cylinders trading profit in the quarter.
Cash flow and net debt
Net cash outflow from operating activities was $4.7m in Q2 2014
compared to an inflow of $6.9m in Q2 2013. There was a cash outflow
from higher working capital of $14.6m in Q2 2014 compared to an
outflow of $3.5m in Q2 2013, reflecting higher receivables in the
AF Gas Cylinders business driven by longer contractual terms on the
virtual pipeline contract in Australia, as well as a higher than
normal level of inventories resulting from changes in demand, which
we expect to reduce over the next twelve months as demand and
supply normalize.
Net cash used in investing activities was $4.1m in Q2 2014
compared to $4.0m in Q2 2013. Purchases of property, plant and
equipment resulted in a cash outflow of $4.8m in Q2 2014 (Q2 2013:
$4.0m). Purchases of intangible assets were $0.2m in Q2 2014 (Q2
2013: $nil). Net cash inflow from investments in joint ventures in
Q2 2014 was $1.1m (Q2 2013: $nil). Q2 2014 includes a cash outflow
of $0.2m for acquisition costs in relation to our Q1 2014 Utah
acquisition. There was a net cash outflow before financing of $8.8m
in Q2 2014 compared to an inflow of $2.9m in Q2 2013.
Q2 2014 cash flows used in financing activities were a net
inflow of $0.8m compared to an outflow of $3.8m in Q2 2013. This
included $1.3m of interest paid to debt-holders (Q2 2013: $1.2m)
and for both years $2.7m of dividends paid. In Q2 2014, we made net
additional borrowings of $4.7m to help fund the working capital
increases. We received $0.3m from the purchase of shares issued as
part of the Group’s employee share purchase arrangements. We also
paid a further $0.2m in fees in relation to the amendment to our
banking facilities.
Total cash flow movements were a net outflow of $8.0m in Q2 2014
compared to a $0.9m outflow in Q2 2013. We had $11.1m of cash and
cash equivalents as at June 30, 2014, compared to an equivalent
figure of $37.0m as at June 30, 2013. As at June 30, 2014, net debt
had increased to $55.4m from $26.6m as at June 30, 2013.
Six-month period ended June 30, 2014
HALF YEAR 2014 HALF YEAR 2013 Gas
Gas Cylinders
Elektron Group Cylinders Elektron
Group $M $M $M
$M $M $M Revenue
132.0 113.2 245.2 133.2 112.2 245.4
Net
revenue (excluding RE surcharge) 132.0 111.7
243.7
133.2
106.4
239.6
Trading profit 3.3 20.2
23.5 10.0 20.2 30.2
Return on Sales %
(Trading profit/Revenue)
2.5%
17.8%
9.6%
7.5% 18.0% 12.3%
On an IFRS reported basis, revenues for the six-month period
were $245.2m compared to $245.4m for the same period of 2013. The
decrease reflects reduced surcharges on rare earths. Net revenue
for the six-month period was $243.7m for 2014, $4.1m higher
compared to the equivalent period in 2013 of $239.6m. Adjusting for
a favorable translation impact of $6.4m, underlying revenue
decreased by $2.3m or 0.9% for the half year of 2014 compared to
the 2013 half year. This decrease was caused in part by the
previously reported issues in the U.S. SCBA market and by reduced
demand in other cylinder sectors, mainly in European markets,
experienced by the Gas Cylinders Division along with the impact of
the abnormally low U.S. countermeasure sales in the Elektron
Division. These negatives obscure advancement in sales in key
strategic areas such as magnesium alloys and zirconium industrial
catalysis.
Trading profit for the six-month period was $23.5m compared to
$30.2m for 2013, down 22.2%. Though underlying net revenue was only
slightly down, there was a much larger profit impact due to the
adverse sales mix in the Gas Cylinders Division. Despite incurring
a disruption to sales of countermeasure powders, the Elektron
Division’s trading profit of $20.2m was in line with prior year,
helped by increased sales in newer product areas. The Gas Cylinders
Division’s trading profit of $3.3m was, however, down 67.0%, with
high development and marketing costs on new products and the
profitability of stronger aluminum cylinder sales unable to
compensate for lower higher-margin composite sales. With
restructuring and other expense of $0.8m, operating profit was
therefore $22.7m, down from $29.6m for the same period in 2013.
Profit before tax for the six-month period at $17.9m was $7.0m
or 28.1% below the same period in 2013. Net income for the
six-month period was $12.9m, down $4.0m from the same period in
2013.
Adjusted net income (as reconciled to net income in Note 4 of
this release) for the six-month period was $15.6m compared to
$19.4m for the same period in 2013.
Adjusted EBITDA (as reconciled to net income in Note 4 of this
release) for the six-month period was $33.1m compared to $38.5m for
the same period in 2013. Net cash outflow from operating activities
for the six-month period was $3.4m compared to an inflow of $16.5m
for the same period in 2013.
Other corporate matters
Acquisition of Truetech and of Innotech products
Following the receipt of certain required regulatory approvals,
we can now confirm the July 29th closing of the acquisition of the
assets and businesses of Truetech Inc. and Innotech Products
Limited. The acquired businesses produce magnesium-based flameless
heating pads for self-heating meals used by the U.S. military and
emergency relief agencies; an extensive line of self-heating meals
and beverages used by military and civilian end-users; chemical
agent detection kits; and chemical decontamination equipment.
Truetech operates a manufacturing and warehousing facility on a
company-owned site in Riverhead, New York, and Innotech operates a
leased manufacturing, assembly and distribution facility in
Cincinnati, Ohio. The acquired businesses have been combined within
Luxfer Magtech Inc., a new wholly-owned subsidiary of Luxfer Group,
and will operate as part of the Group’s specialty materials
Elektron Division. On closing, we paid an initial consideration of
$59m and would expect to pay in early 2015 a further deferred
element of $5m.
The expertise in the Elektron Division on designing magnesium
alloys and adsorbent zirconium chemicals is expected to give added
potential for improvements to the products of the acquired
businesses in the coming years, and the greater geographical
coverage of Luxfer Group offers, we believe, further prospects to
grow the acquired businesses.
Update on the acquisition of additional CNG cylinder
manufacturing facility
As reported in Q1 2014, we acquired a business in Utah
specializing in the design and manufacture of high-pressure
composite Type 4 cylinders for compressed natural gas (CNG); this
business is now operating within the Gas Cylinders Division. We
have now paid $2.8m in consideration, net of cash acquired, and we
estimate that the aggregate deferred consideration over the next
three years will amount to $3.4m, which is discounted under IFRS
accounting to a figure of $2.5m as at June 30, 2014. The operation
is not due to start manufacturing Luxfer cylinders until Q3 2014,
so we have also incurred additional facility costs in Q2 2014
without any contribution from incremental cylinder sales.
Strategic products update
Intelligent Oxygen System™ (IOS) - In the medical market we have
been incurring additional costs as we complete development of our
IOS medical composite cylinder system and work through the
qualification process. In Q1 2014, the quality system at our U.K.
cylinder facility, where we plan to manufacture our IOS medical
oxygen delivery system, was approved to the ISO 13485 Medical
Devices standard, and in Q2 we completed key final data testing on
the Smartflow® regulator around which the IOS device is based,
enabling us to proceed towards requesting CE (Conformité
Européenne) approval in 2015.
Alternative fuel (AF) containment – We are well advanced in the
development of a new range of Type 4 (polymer-lined) composite
cylinders, which we expect to manufacture at our newly acquired
Utah facility in Q3 of 2014. A new sector for Luxfer is being
targeted: the North American class 8 heavy-duty truck market. In Q2
we manufactured samples of these cylinders at our Riverside
facility, and in early Q3 we made our first sales of Type 4
composite cylinder products. We have also developed a range of
Luxfer-branded accessory equipment for CNG systems, including
in-house-developed specialist CNG valves and pressure-release
devices.
Bulk gas transportation – We have now completed the main
shipments of the virtual pipeline order for the Australian mine
reported in Q1 2014. We believe potential remains for further
module sales related to the same contract, and we have received
many inquiries about the solution we developed for the Australian
mining market.
Magnesium in aircraft interiors – In Q1 we were pleased to
confirm another milestone in this project when the FAA issued
details of the laboratory scale flame test criteria for magnesium
alloys to be used in aircraft seating. In the same quarter we
announced the first seating installation, by our customer, Zim
Flugsitz, in a low-volume European application, and in Q2 this
customer marketed its new magnesium-intensive seating at the
Hamburg aircraft interiors trade show, at which Luxfer also
exhibited. We also continue to work with other aircraft seating
manufacturers, seeking larger-scale applications for expected
commercialization in 2015 and onwards.
Outlook for 2014
The first half of 2014 has been affected by reduced sales in
certain markets and by costs of developing new products and
sectors. On top of continuing depressed European markets, the Gas
Cylinders Division’s important SCBA market has been disrupted by
regulatory issues, while the Elektron Division, which would
otherwise be ahead of prior year, has been held back by a slowdown
in demand for military-grade magnesium powders.
The disruption to SCBA sales caused by delayed approvals is
easing, with several approved breathing sets now being sold, and
June was our best month so far this year for U.S. sales in this
market. We believe that Q3 will still be somewhat affected since
some customers are still awaiting approval for their new products,
but we expect the market to return to full flow in Q4.
We reported that in Q1 we saw a reduction in orders for
alternative fuel (AF) cylinders, including somewhat flat markets
for bus and medium truck conversions, and this continued during Q2.
Although we shipped the balance of the major Australian AF virtual
pipeline modules during Q2, our North American JV is below the
targeted level of new business in the bulk transport sector, and we
have re-invigorated sales and marketing efforts and are in the
course of re-examining its product offerings. Since the end of Q2
we have sold the first of our new range of Type 4 (polymer-lined)
cylinders: a 22-inch cylinder for pick-up truck conversion to CNG.
We also started manufacturing our mainstream 26-inch Type 4
cylinder, aimed at the nascent heavy-duty truck market. Getting
these products out of development and into the market will give a
double benefit since we are currently incurring associated
development, launch marketing and under-utilized facility
costs.
Following the acquisition of Luxfer Utah, and as part of our
effort to continually take cost out of the businesses, we have
eliminated several overhead staff positions in the Gas Cylinders
Division, resulting in a restructuring charge in the first half of
2014, but with the prospect of generating annualized savings of
approximately $2m, to benefit Q4 onwards.
In the Elektron Division, the outage at one of our defense
customers producing countermeasure flares, which only affected five
weeks of the first quarter, had a bigger impact in Q2. While that
customer is now back in low-level production, the overall demand
outlook from all U.S. customers for military powders in the balance
of the year looks quite weak, and we now expect that sector to end
up around 40% down on 2013. In response we have also reduced
headcount in the powder manufacturing operations.
Elsewhere in the Elektron Division, we continue to see modest
improvement over 2013, but demand in several sectors remains
somewhat difficult to predict.
While there will be ups and downs, we remain optimistic that
second-half profits will be a positive improvement over the first
half. The main contribution to this improvement is expected from
the Gas Cylinders Division with a normalizing SCBA market and the
launch of the new cylinder range to be manufactured at our (as
acquired, idle) Utah facility. Even with this expected improvement,
however, the Gas Cylinders Division’s full-year result will now
inevitably be well down on prior year.
For various reasons, including deferred terms on the Australian
virtual pipeline contract, we have seen a large increase in working
capital over the last year, and we plan to return a good proportion
of this to cash over the next twelve months.
There are several positive signs in the Elektron Division, but
the current weakness in the important military powders market will
mean that the divisional full-year result is likely to be similar
to prior year on a like-for-like basis. Our new U.S.-based
acquisition is expected to give an approximately 10% boost to the
Elektron Division’s revenues, with the full benefit from Q4
onwards.
Even before taking account of the expected contribution from the
newly-acquired businesses of Truetech and Innotech, we expect Q4 to
be our best quarter of the year, and this encourages us as to the
outlook for 2015. In 2015 it seems likely that we will still be
suffering the effects of de-stocking by the U.S. Department of
Defense, but we expect the additional effects of manufacturing
disruption and de-stocking by our direct countermeasure customers
experienced in 2014 to be complete. We expect the SCBA market to be
back on a growth track, and we will have what we believe will be
the widest range of AF containment packages in the market and a
full year of a new sector for the Group in AF cylinders for
heavy-duty trucks. For both Cylinders and Elektron, European
industrial markets are recovering, albeit very slowly, and we
continue to make good progress on several of our other key
strategic projects, including getting our Elektron® magnesium
alloys into the civil airliner sector, and our added-value
Intelligent Oxygen System™ (IOS), which we now expect to launch
into the U.K. medical market towards the end of 2015.
CONSOLIDATED INCOME STATEMENT FOR THE
THREE-MONTH AND SIX-MONTH PERIODS ENDED
JUNE 30, 2014 AND 2013
(UNAUDITED)
Three-month periods
ended June 30,
Six-month periods
ended June 30,
2014 2013
2014
2013
CONTINUING OPERATIONS
$M
$M
$M
$M
REVENUE 121.9 123.0
245.2 245.4
Cost of sales
(94.6 )
(92.5 )
(189.0 )
(186.6 ) Gross profit
27.3 30.5
56.2 58.8
Distribution costs
(2.2 ) (1.5 )
(4.3 )
(3.1 ) Administrative expenses
(13.7 ) (13.8 )
(28.2 ) (25.6 ) Share of results of joint venture
(0.2 ) 0.1
(0.2 ) 0.1
TRADING
PROFIT 11.2 15.3
23.5 30.2 Restructuring and
other income (expense)
(0.8 ) (0.2 )
(0.8
) (0.6 )
OPERATING PROFIT 10.4 15.1
22.7 29.6 Acquisitions and disposals
(0.1 ) -
(0.3 ) - Finance income Interest received
0.1
0.1
0.2 0.1 Finance costs Interest costs
(1.7
) (1.5 )
(3.2 ) (3.0 ) IAS 19R – retirement
benefits finance charge
(0.7 ) (0.9 )
(1.4
) (1.8 ) Unwind of discount on deferred consideration from
acquisitions
(0.1 ) -
(0.1 ) -
PROFIT ON OPERATIONS BEFORE TAXATION 7.9 12.8
17.9 24.9 Tax expense
(2.2 ) (4.2 )
(5.0 ) (8.0 )
NET INCOME FOR THE PERIOD
5.7 8.6
12.9 16.9
Attributable to: Equity shareholders
5.7 8.6
12.9 16.9
NET INCOME FOR THE PERIOD
5.7 8.6
12.9 16.9
Accounting charges relating to acquisitions and disposals of
businesses Unwind of discount on deferred consideration from
acquisitions
0.1 -
0.1 - Acquisitions and disposals
0.1 -
0.3 - IAS 19R – retirement benefits finance
charge
0.7 0.9
1.4 1.8 Restructuring and other
(income) expense
0.8 0.2
0.8 0.6 Other share based
compensation charges
0.7
0.6
1.0 0.7
Tax thereon
(0.5 )
(0.3 )
(0.9 ) (0.6
)
ADJUSTED NET INCOME 7.6
10.0
15.6
19.4
CONSOLIDATED STATEMENT OF COMPREHENSIVE
INCOME FOR THETHREE-MONTH AND SIX-MONTH PERIODS ENDED
JUNE 30, 2014 AND 2013
(UNAUDITED)
Three-month periods
ended June 30,
Six-month periods
ended June 30,
2014 2013
2014 2013
$M $M
$M $M
Net income for the period 5.7 8.6
12.9 16.9
Other comprehensive income movements: Exchange
differences on translation of foreign operations
2.5 0.3
2.6 (6.0 ) Fair value movements in cash flow hedges
0.6 (3.6 )
0.5 (3.0 ) Transfers to income statement
on cash flow hedges
1.0 0.4
0.7 (0.4 ) Deferred tax
on cash flow hedges
(0.3 ) 0.8
(0.2 ) 0.8
Hedge accounting
income adjustments 1.3 (2.4 )
1.0 (2.6 )
Total hedge accounting and translation of foreign operation
movements 3.8 (2.1 )
3.6
(8.6 ) Remeasurement of defined benefit
retirement plans
1.5 6.3
(6.2 ) 17.3 Deferred
tax on retirement benefit changes
(0.6 )
(2.1 )
1.3 (5.5 )
Retirement
benefit changes 0.9 4.2
(4.9 ) 11.8
Total other comprehensive income
movements for the period
4.7 2.1
(1.3 )
3.2
Total comprehensive income for the period
10.4 10.7
11.6 20.1
Attributed to:
Equity shareholders
10.4 10.7
11.6 20.1
UNAUDITED CONSOLIDATED BALANCE SHEET AS
OF
JUNE 30, 2014 AND 2013 AND AUDITED
DECEMBER 31, 2013
June 30, June 30, December 31,
2014 2013 2013
$M
$M
$M
ASSETS
Non-current assets Property, plant and equipment
140.0 126.1 137.9 Intangible assets
47.8 35.9 41.4
Investments
6.7 3.4 7.9 Deferred tax assets
16.1 16.6 15.8
210.6 182.0 203.0
Current assets Inventories
108.9 83.9 94.1 Trade and other receivables
83.9 72.2
68.6 Income tax receivable
0.7 0.5 2.0 Cash and short term
deposits
11.1 37.0
28.4
204.6
193.6 193.1
TOTAL
ASSETS 415.2 375.6
396.1
EQUITY AND LIABILITIES
Ordinary share
capital
25.3 25.3 25.3 Deferred share capital
150.9
150.9 150.9 Share premium account
55.8 55.6 55.6 Retained
earnings
319.9 301.9 317.3 Own shares held by ESOP
(0.4 ) (0.5 ) (0.5 ) Other capital reserves
3.3 1.8 2.6 Hedging reserve
0.7 (2.2 ) (0.3 )
Translation reserve
(22.8 ) (34.5 ) (25.4 ) Merger
reserve
(333.8 ) (333.8 )
(333.8 ) Capital and reserves attributable to the
Group’s equity holders
198.9
164.5 191.7 Total equity
198.9 164.5 191.7
Non-current liabilities Bank and other loans
66.5 63.6 63.8 Retirement benefits
72.4 71.8 67.6
Deferred tax liability
4.2 2.9 5.5 Deferred consideration
2.1 - - Provisions
2.4
2.4 2.2
147.6 140.7 139.1
Current liabilities Trade and other payables
65.8
68.0 63.2 Current income tax liabilities
0.5 0.7 0.3
Deferred consideration
0.4 - - Provisions
2.0 1.7 1.8
68.7 70.4
65.3 Total liabilities
216.3 211.1 204.4
TOTAL EQUITY AND LIABILITIES
415.2 375.6 396.1
CONSOLIDATED CASH FLOW STATEMENT FOR
THE THREE-MONTH AND SIX-MONTH PERIODS ENDED JUNE 30, 2014 AND
2013
(UNAUDITED)
Three-month periods
ended June 30,
Six-month periods
ended June 30,
2014 2013
2014
2013
$M
$M
$M
$M
RECONCILIATION OF CASH FLOWS FROM OPERATING ACTIVITIES Net
income for the period
5.7 8.6
12.9 16.9 Adjustments
to reconcile net income for the period to net cash from operating
activities: Income taxes
2.3 3.4
5.1 6.1 Deferred
income taxes
(0.1 ) 0.8
(0.1 ) 1.9
Depreciation and amortization
4.3 3.9
8.6 7.6 Share
based compensation charges
0.8 0.7
1.1 1.0 Net
interest costs
1.6 1.4
3.0 2.9 IAS 19 finance charge
0.7 0.9
1.4 1.8 Unwind of discount on deferred
consideration from acquisitions
0.1 -
0.1 -
Acquisitions and disposals
0.1 -
0.3 - Share of
results of joint ventures
0.2 (0.1 )
0.2 (0.1 )
Changes in operating assets and liabilities: (Increase)/decrease in
receivables
(4.5 ) 2.3
(15.6 ) (0.4 )
Increase in inventories
(1.3 ) (1.7 )
(13.9
) (2.0 ) (Decrease)/increase in payables
(8.8
) (4.1 )
1.6 (7.9 ) Movement in retirement benefit
obligations
(2.6 ) (2.7 )
(4.9 ) (4.3 )
Movement in provisions
0.5 (0.1 )
0.4 (0.4 ) Income
tax paid
(3.7 ) (6.4 )
(3.6 ) (6.6 )
NET CASH FLOWS
(USED IN)/FROM CONTINUING OPERATING ACTIVITIES
(4.7 ) 6.9
(3.4 ) 16.5
CASH FLOWS FROM
INVESTING ACTIVITIES Purchases of property, plant and equipment
(4.8 ) (4.0 )
(7.9 ) (7.9 ) Purchases
of intangible assets
(0.2 ) -
(0.5 ) -
Investment in Joint Venture – equity funding
- -
-
(2.5 ) Investment in Joint Venture – repayment of debt funding
1.0 -
1.0 - Interest income received from Joint
Ventures
0.1 -
0.2 - Net cash flow on purchase of
business
(0.2 ) -
(2.9 ) -
NET CASH USED
IN INVESTING ACTIVITIES (4.1 )
(4.0 )
(10.1 )
(10.4 )
NET CASH FLOW BEFORE FINANCING (8.8
) 2.9
(13.5
) 6.1
FINANCING ACTIVITIES
Interest and similar finance costs paid on banking facilities
(0.3 ) (0.2 )
(0.5 ) (0.4 ) Interest
paid on Loan Notes due 2018
(1.0 ) (1.0 )
(2.0
) (2.0 ) Dividends paid
(2.7 ) (2.7 )
(5.4 ) (5.4 ) Draw down on banking facilities
5.0 -
5.0 - Repayment of banking facilities and other
loans
(0.3 ) -
(0.3 ) - IPO share issue
costs
- -
- (0.3 ) Purchase of shares from ESOP
0.1 -
0.1 - Proceeds from issue of shares
0.2
-
0.2 - Other interest received
- 0.1 0.1 Amendment
to banking facilities – financing costs
(0.2 )
-
(1.5 )
-
NET CASH FLOWS FROM/(USED IN) FINANCING
ACTIVITIES 0.8 (3.8 )
(4.4 ) (8.0 )
NET DECREASE IN
CASH AND CASH EQUIVALENTS (8.0 )
(0.9 )
(17.9 )
(1.9 ) Net decrease in cash and cash equivalents
(8.0
) (0.9 )
(17.9 ) (1.9 ) Net foreign exchange
differences
0.6 0.9
0.6 (1.3 ) Cash and cash
equivalents at beginning of period
18.5
37.0
28.4
40.2
Cash and cash equivalents at end of period
11.1 37.0
11.1 37.0
1. Revenue and segmental analysis
For management purposes, the Group is organized into two
operational divisions, Gas Cylinders and Elektron. The tables below
set out information on the results of these two reportable
segments. Management monitors the operating results of its
divisions separately for the purpose of making decisions about
resource allocation and performance assessment. Segment performance
is evaluated based on trading profit or loss, defined as operating
profit or loss before restructuring and other expense. All
inter-segment sales are made on an arm’s length basis.
REPORTING SEGMENTS:
Three-month period ended June 30, 2014 Three-month
period ended June 30, 2013 Gas
Continuing Gas Continuing
Cylinders Elektron Unallocated
Activities Cylinders Elektron
Unallocated Activities $M
$M
$M
$M
$M
$M
$M
$M
Revenue Segment Revenue 65.9 56.4 -
122.3 64.8 58.3 -
123.1 Inter-segment sales - (0.4 )
-
(0.4 ) -
(0.1 ) -
(0.1 ) Sales to external customers
65.9
56.0 - 121.9 64.8 58.2 -
123.0 Result Trading profit
1.7 9.5
- 11.2 4.8 10.5 - 15.3
Restructuring and other income (expense) (0.5 ) (0.2
) (0.1 )
(0.8 )
(0.1 ) - (0.1 )
(0.2 ) Operating profit 1.2 9.3 (0.1 )
10.4
4.7 10.5 (0.1 )
15.1 Acquisitions and disposals (0.1 ) - -
(0.1 ) - - - - Net interest costs - - (1.6 )
(1.6 ) - - (1.4 )
(1.4 ) IAS 19 finance
charge - - (0.7 )
(0.7 ) - - (0.9 )
(0.9
) Unwind of discount on deferred consideration from
acquisitions (0.1 ) - -
(0.1 ) -
- -
-
Profit before tax 1.0 9.3 (2.4 )
7.9 4.7 10.5 (2.4 )
12.8 Tax expense
(2.2 )
(4.2 ) Net income for the period
5.7
8.6
Other segment information Segment assets 205.3 166.6 43.3
415.2 165.5 146.7 63.4
375.6 Segment liabilities
(38.4 ) (24.3 ) (153.6 )
(216.3 ) (37.7 ) (23.1 )
(150.3 )
(211.1 ) Net
assets/(liabilities) 166.9 142.3
(110.3 )
198.9 127.8
123.6 (86.9 )
164.5 Capital expenditure: Property, plant and
equipment 1.9 3.1 -
5.0 2.2 2.1 -
4.3 Capital
expenditure: Intangible assets - 0.2 -
0.2 - - -
-
Depreciation and amortization 1.9 2.4
-
4.3 1.7
2.2 -
3.9 Six-month period ended June 30,
2014 Six-month period ended June 30, 2013
Gas Continuing Gas
Continuing Cylinders Elektron
Unallocated Activities Cylinders
Elektron Unallocated Activities
$M
$M
$M
$M
$M
$M
$M
$M
Revenue Segment Revenue 132.0 113.8 -
245.8
133.2 112.6 - 245.8 Inter-segment sales
- (0.6 ) -
(0.6 ) -
(0.4 ) -
(0.4 ) Sales to external customers
132.0
113.2 - 245.2 133.2 112.2
- 245.4 Result Trading profit
3.3
20.2 - 23.5 10.0 20.2 -
30.2 Restructuring and other income (expense) (0.5 )
(0.2 ) (0.1 )
(0.8
) (0.3 ) - (0.3 )
(0.6 ) Operating profit 2.8 20.0 (0.1 )
22.7 9.7 20.2 (0.3 )
29.6 Acquisitions and disposals
(0.3 ) - -
(0.3 ) - - -
- Net interest costs -
- (3.0 )
(3.0 ) - - (2.9 )
(2.9 ) IAS
19 finance charge - - (1.4 )
(1.4 ) - - (1.8 )
(1.8 ) Unwind of discount on deferred consideration
from acquisitions (0.1 ) -
-
(0.1 ) -
- -
- Profit before tax 2.4 20.0 (4.5 )
17.9 9.7
20.2 (5.0 )
24.9 Tax expense
(5.0 )
(8.0 ) Net income for the
period
12.9
16.9
Other segment information Segment assets 205.3 166.6
43.3
415.2 165.5 146.7 63.4
375.6 Segment liabilities
(38.4 ) (24.3 ) (153.6 )
(216.3 ) (37.7 ) (23.1 )
(150.3 )
(211.1 ) Net
assets/(liabilities) 166.9 142.3
(110.3 )
198.9 127.8
123.6 (86.9 )
164.5 Capital expenditure: Property, plant and
equipment 3.6 4.6 -
8.2 4.0 3.5 -
7.5 Capital
expenditure: Intangible assets 0.2 0.3 -
0.5 - - -
-
Depreciation and amortization 3.8 4.8
-
8.6 3.4
4.2 -
7.6
2. Calculation of net debt
Three-month periods ended June
30,
Six-month periods ended June
30,
2014 2013
2014
2013
Net debt is represented by:
$M
$M
$M
$M
Non-current bank and other loans
(66.5 ) (63.6
)
(66.5 ) (63.6 ) Less: Cash and short term deposits
11.1 37.0
11.1 37.0 Net debt at the end of
the period
(55.4 ) (26.6 )
(55.4 ) (26.6 )
3. Other income (expense) items
a) Restructuring and other
income (expense)
Three-month periods Six-month periods
ended June 30, ended June 30, 2014 2013
2014 2013
$M
$M
$M
$M
Charged to Operating profit: Rationalization of operations
(0.7 ) (0.1 )
(0.7 ) (0.3 ) I.P.O.
related share based compensation charges
(0.1 )
(0.1 )
(0.1 )
(0.3 )
(0.8 ) (0.2 )
(0.8 ) (0.6 )
b) Acquisitions and
disposals
Three-month periods
ended June 30,
Six-month periods
ended June 30,
2014 2013
2014 2013
$M
$M
$M
$M
Charged to Non-operating profit: Net acquisition costs
(0.1 ) -
(0.3 ) -
(0.1
) -
(0.3 )
-
Rationalization of operations
For the three-month and six-month periods ended June 30, 2014,
$0.5 million and $0.2 million of costs have been incurred in
relation to rationalization costs in our Gas Cylinders Division and
our Elektron Division, respectively (three-month and six-month
periods ended June 30, 2013: $0.1 million and $0.3 million,
respectively, were incurred in our Gas Cylinders Division).
I.P.O.-related share-based compensation charges
For the three-month and six-month periods ended June 30, 2014, a
charge of $0.1 million was recognized in the income statement under
IFRS 2 in relation to share options granted as part of the initial
public offering in 2012 (three-month and six-month periods ended
June 30, 2013: $0.1 million and $0.3 million, respectively).
Net acquisition costs
For the three-month and six-month periods ended June 30, 2014,
$0.1 million and $0.3 million of costs, respectively, have been
incurred in relation to the acquisition of a small composite
cylinder manufacturer and associated production assets in Utah.
4. Reconciliation of non-GAAP measures
The following table presents a reconciliation of Adjusted net
income and Adjusted EBITDA to net income for the period, the most
comparable IFRS measure.
Three-month periods Six-month
periods ended June 30, ended June 30, 2014
2013
2014 2013
$M
$M
$M
$M
Net income for the period
5.7
8.6
12.9
16.9 Accounting charges relating to acquisitions and
disposals of businesses Unwind of discount on deferred
consideration from acquisitions
0.1 -
0.1 -
Acquisitions and disposals
0.1 -
0.3 - IAS 19 –
retirement benefits finance charge
0.7 0.9
1.4 1.8
Restructuring and other (income) expense
0.8 0.2
0.8
0.6 Other share based compensation charges
0.7
0.6
1.0
0.7 Tax thereon
(0.5
) (0.3 )
(0.9 )
(0.6 ) Adjusted net income
7.6
10.0
15.6
19.4 Add back: Tax thereon
0.5
0.3
0.9 0.6 Tax expense
2.2 4.2
5.0 8.0
Interest costs (net)
1.6 1.4
3.0 2.9 Depreciation and
amortization
4.3 3.9
8.6 7.6
Adjusted EBITDA
16.2 19.8
33.1 38.5
Management believes that Adjusted net income and Adjusted EBITDA
are key performance indicators used by the investment community and
that the presentation of these items will enhance an investor’s
understanding of our results of operations. Adjusted net income and
Adjusted EBITDA should not be considered in isolation by investors
as an alternative to net income for the period, as an indicator of
our operating performance or as a measure of our profitability.
5. Earnings per share
The Group calculates earnings per share in accordance with IAS
33. Basic income per share is calculated based on the weighted
average common shares outstanding for the period presented. The
weighted average number of shares outstanding is calculated by
time-apportioning the shares outstanding during the year.
For the purpose of calculating diluted earnings per share, the
weighted average number of ordinary shares outstanding during the
financial year have been adjusted for the dilutive effects of all
potential ordinary shares and share options granted to
employees.
Following the approval of a two-for-one share split at the
Annual General Meeting on May 29, 2014, each £0.50 ordinary share
now represents 1 American Depositary Share (ADS), resulting in the
earnings per ordinary share being equivalent to the earnings per
ADS.
The ADSs of Luxfer Holdings PLC are listed on the New York Stock
Exchange following an initial public offering on October 3, 2012.
The company’s £0.50 ordinary shares are not traded on any
recognized stock exchange. The Depository for the ADSs holds 1
£0.50 ordinary share for every 1 ADS traded, through American
Depositary Receipts.
Under IAS 33, the number of shares used in the earnings per
share calculations for the prior periods shown has been adjusted to
achieve comparability.
Three-month periods Six-month periods
ended June 30, ended June 30, 2014
2013
2014 2013
$M
$M
$M
$M
Basic earnings: Basic earnings attributable to ordinary
shareholders
5.7 8.6
12.9 16.9
Adjusted earnings: Accounting charges relating to
acquisitions and disposals of businesses Unwind of discount on
deferred consideration from acquisitions
0.1 -
0.1 - Acquisitions and disposals
0.1 -
0.3 - IAS 19 – retirement benefits finance charge
0.7
0.9 1.4 1.8 Restructuring and other (income) expense
0.8 0.2 0.8 0.6 Other share based compensation
charges
0.7 0.6
1.0 0.7 Tax thereon
(0.5 ) (0.3 )
(0.9 ) (0.6 )
Adjusted
earnings 7.6 10.0
15.6 19.4
Weighted average number of £0.50 ordinary shares: For basic
earnings per share
26,861,269 26,812,652
26,844,430
26,813,726 Exercise of share options
1,395,274
1,255,476
1,329,369
1,201,200 For diluted earnings per share
28,256,543 28,068,128
28,173,799 28,014,926
Earnings per share using weighted average number of ordinary
shares outstanding: Basic Adjusted
$ 0.28
$0.37
$ 0.58 $ 0.72 Unadjusted
$ 0.21
$0.32
$ 0.48 $
0.63
Diluted Adjusted
$ 0.27 $0.36
$ 0.55 $ 0.69 Unadjusted
$ 0.20
$0.31
$ 0.46 $ 0.60
Each £0.50 ordinary share now represents
one American Depositary Share, as listed and quoted on the New York
Stock Exchange.
6. Retirement benefits
The principal defined benefit pension plan in the U.K. is the
Luxfer Group Pension Plan. The Group’s other arrangements are less
significant than the Luxfer Group Pension Plan, the largest being
the BA Holdings Inc Pension Plan in the United States.
The actuarial assumptions used to estimate the IAS 19 accounting
position of the Group’s defined benefit pension plans have been
updated for market conditions at June 30, 2014.
The discount rate for the U.K. plan has decreased by 0.2% per
annum from 4.5% at December 31, 2013, to 4.3% at June 30 2014.
Long-term inflation expectations have decreased by 0.1% per annum
from 3.4% at December 31, 2013 to 3.3% at June 30, 2014. The
combined effect of the changes has been to increase the projected
benefit obligation by approximately $7 million relative to that
expected. There have also been slightly higher-than-expected
returns on U.K. plan assets of $3 million, which, combined with the
change in the projected benefit obligation and the net
charges/contributions and translation impact of a positive $1
million, has led to the deficit on the U.K. plan increasing by
approximately $3 million.
In the United States, the discount rate has decreased by 0.5%
from 4.9% at December 31, 2013 to 4.4% at June 30, 2014. This has
increased the projected benefit obligation by approximately $3.4
million relative to that expected. There were better-than-expected
returns on U.S. plan assets of $1.2 million, which, combined with
the change in the projected benefit obligation and the net
charges/contributions of the scheme of a positive $0.8 million, has
led to the deficit on the U.S. plan increasing by approximately
$1.4 million.
The movement in the pension liability is shown below:
Three-month periods
ended June 30,
Six-month periods
ended June 30,
2014 2013
2014 2013
$M
$M
$M
$M
Opening balance
74.1 79.8
67.6 96.7 Charged to the
Income Statement
2.5 2.4
5.0 5.1 Cash contributions
(4.4 ) (4.2 )
(8.5 ) (7.6 )
(Credited)/charged to the Statement of Comprehensive Income
(1.5 ) (6.3 )
6.2 (17.3 ) Exchange adjustments
1.7 0.1
2.1
(5.1 ) Closing balance
72.4
71.8
72.4 71.8
7. Dividends paid and proposed
Three-month periods
ended June 30,
Six-month periods
ended June 30,
2014 2013
2014 2013
$M
$M
$M
$M
Dividends declared and paid during the period: Interim dividend
paid February 6, 2013 ($0.10 per ADS)
- -
- 2.7
Interim dividend paid May 8, 2013 ($0.10 per ADS)
- 2.7
- 2.7 Interim dividend paid February 5, 2014 ($0.10 per ADS)
- -
2.7 - Interim dividend paid May 7, 2014 ($0.10
per ADS)
2.7 - 2.7
- 2.7
2.7
5.4 5.4
Three-month periods
ended June 30,
Six-month periods
ended June 30,
2014 2013
2014 2013
$M $M
$M
$M
Dividends proposed after June 30 (not recognized as a liability as
at June 30): Interim dividend paid August 7, 2013 ($0.10 per ADS)
- 2.7
- 2.7 Interim dividend proposed and payable
August 6, 2014 ($0.10 per ADS)
2.7
- 2.7 -
2.7
2.7
2.7 2.7
8. Share based compensation
Luxfer Holdings PLC Long-Term Umbrella Incentive Plan
(“LTIP”) and Luxfer Holdings PLC Non-Executive Directors Equity
Incentive Plan (“Director EIP”)
On March 21, 2014, 201,870 Restricted Stock Units and Options
over ADSs were granted under the LTIP. The total fair value of the
awards amounts to $2.5 million, of which $1.2 million will be
charged in the year ending December 31, 2014.
Following the Annual General Meeting on May 29, 2014, 12,517
Restricted Stock Units and Options over ADSs were granted under the
Director EIP.
9. Acquisitions
Acquisition of additional CNG cylinder manufacturing
facility
In March 2014 the Group acquired a business specializing in the
design and manufacture of composite cylinders and the associated
production assets in Utah. This provides our North American Gas
Cylinders business with a facility purpose-built for the
manufacture of Type 4 (polymer-lined) composite cylinder products,
which are being targeted initially at the class 8 heavy-duty truck
market, where an increasing rate of conversion from diesel to CNG
is widely anticipated. We are in the final stages of developing a
new range of larger-diameter Type 4 cylinders for growing CNG
markets to complement our existing lightweight range of Type 3
(aluminum-lined) cylinder products and systems, and our plan is for
the new range to be made in Utah.
Assets acquired and liabilities assumed
Acquisition fair value $M Property,
plant and equipment
1.1 Intangible assets
0.7 Cash
and short term deposits
0.1 Trade and other receivables
0.4 Total assets
2.3 Trade and other payables
(0.9 ) Bank and other loans
(0.3 )
Total liabilities
(1.2 ) Net assets acquired
1.1 Total identifiable net assets at
fair value 1.1 Goodwill arising on acquisition
4.1 Gross purchase consideration
5.2 Represented by: Amounts paid
2.8 Contingent consideration liability
2.4
5.2
The contingent consideration was estimated
to be $3.4 million and is shown above net of the impact of
discounting, using a rate of 14%. The contingent consideration is
linked into the future profitability of the company and
substantially all of it will be payable at March 31, 2017. The
contingent consideration is shown in the balance sheet as at June
30, 2014 at $2.5 million, which is net of the unwind of discount to
date of $0.1 million.
As the acquisition occurred late in the
first quarter, much of the acquisition accounting surrounding the
estimates of consideration could not be completed until the second
quarter. There is also still ongoing work relating to working
capital adjustments that may impact the estimate of
consideration.
June 30, 2014
$M
Net acquisition costs: Transaction costs
0.3
0.3 Net cashflow on purchase of
business: Included in net cashflows from investing
activities: Amounts paid
2.8 Cash acquired
(0.1
) Acquisition costs
0.3 Less: acquisition costs
accrued
(0.1 )
2.9
Transaction costs were $0.3 million, of which $0.2 million are
included in cashflows from operating activities with the remainder
accrued on the balance sheet.
The post-acquisition contribution to revenue and profit before
was $0.4 million revenue and a loss of $0.3 million. Had the
acquisition occurred at the beginning of the year, the contribution
to revenue and profit before tax would have been $1.1 million
revenue and a loss of $0.5 million.
Acquisition of Truetech, Inc. and of Innotech Products,
Ltd.
In July 2014, the Group closed the acquisition of two related
businesses: Truetech and Innotech Products. The acquired businesses
produce magnesium-based flameless heating pads for self-heating
meals used by the U.S. military and emergency relief agencies; an
extensive line of self-heating meals, beverages and soups used by
military and civilian end-users; chemical agent detection kits and
chemical decontamination equipment. Truetech operates a
manufacturing and warehousing facility on a company-owned site in
Riverhead, New York, and Innotech operates a leased manufacturing,
assembly and distribution facility in Cincinnati, Ohio. The
acquired businesses have been combined within Luxfer Magtech Inc.,
a new wholly-owned subsidiary of Luxfer Group, and will operate as
part of the Group’s specialty materials Elektron Division. On
completion, initial consideration of $59 million was paid and it is
expected that a further deferred element of $5 million will be paid
in early 2015.
10. Amendment to banking facilities
On March 25, 2014, the Group amended its banking facilities. The
new arrangements provide an expanded $150 million of committed
revolving credit facilities, at slightly lower costs to previous
terms, and also provide up to an additional $50 million via a
standby accordion facility. The current facilities were due to
mature in early May 2015, but the amended facility will now be
extended to the end of April 2019. The cost of extending these
facilities was an additional $1.3 million commitment fee plus legal
costs of $0.2 million. The private placement notes and the
revolving credit facility are unsecured.
Luxfer GroupDan Stracner, Director of Investor RelationsU.S.
telephone number: +1 951-341-2375dan.stracner@luxfer.net
Luxfer (NYSE:LXFR)
過去 株価チャート
から 6 2024 まで 7 2024
Luxfer (NYSE:LXFR)
過去 株価チャート
から 7 2023 まで 7 2024